*Fund Houses Recommendations* CLSA on *Tata Comm:* Maintain Outperform on Company, target price at Rs 2100/Sh (Positive) Jefferies on *Max Health:* Maintain Buy on Company, target price at Rs 1400/Sh (Positive) Nomura on *Dr Reddy’s:* Maintain Buy on Company, target price at Rs 1575/Sh (Positive) MS on *Life Insurance sector:* Individual new sum assured growth stronger that individual APE for most large players: Morgan Stanley on India Life Insurance. (Positive) HSBC on *AMCs:* SIP flows up, lump sum flows weak. Valuations of AMCs are now at peak (Neutral) GS on *HDFC Life:* Expect moderate H1 growth followed by a pickup in H2, target price at Rs 830/Sh (Neutral) Citi on *HCL tech:* Maintain Neutral on Company, target price at Rs 1510/Sh (Neutral) Citi on *Britannia:* Maintain Buy on Company, target price at Rs 5645/Sh (Neutral) Citi on *Hind Zinc:* Maintain Sell on Company, target price at Rs 400/Sh (Neutral) UBS on *PayTM:* Maintain Neutral on Company, target price at Rs 1000/Sh (Neutral) GS on *United Spirits:* Maintain Buy on Company, target price at Rs 1700/Sh (Neutral) Macquarie on *United Spirits:* Maintain Underperform on Company, target price at Rs 1250/Sh (Negative)